Literature DB >> 22687181

Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease.

Jeffrey A Glassberg1, Jason Wang, Robyn Cohen, Lynne D Richardson, Michael R DeBaun.   

Abstract

OBJECTIVES: The objective was to identify clinical, social, and environmental risk factors for increased emergency department (ED) use in children with sickle cell disease (SCD).
METHODS: This study was a secondary analysis of ED utilization data from the international multicenter Silent Cerebral Infarct Transfusion (SIT) trial. Between December 2004 and June 2010, baseline demographic, clinical, and laboratory data were collected from children with SCD participating in the trial. The primary outcome was the frequency of ED visits for pain. A secondary outcome was the frequency of ED visits for acute chest syndrome.
RESULTS: The sample included 985 children from the United States, Canada, England, and France, for a total of 2,955 patient-years of data. There were 0.74 ED visits for pain per patient-year. A past medical history of asthma was associated with an increased risk of ED utilization for both pain (rate ratio [RR] = 1.28, 95% confidence interval [CI] = 1.04 to 1.58) and acute chest syndrome (RR = 1.60, 95% CI = 1.03 to 2.49). Exposure to environmental tobacco smoke in the home was associated with 73% more ED visits for acute chest syndrome (RR = 1.73, 95% CI = 1.09 to 2.74). Each $10,000 increase in household income was associated with 5% fewer ED visits for pain (RR = 0.95, 95% CI = 0.91 to 1.00, p = 0.05). The association between low income and ED utilization was not significantly different in the United States versus countries with universal health care (p = 0.51).
CONCLUSIONS: Asthma and exposure to environmental tobacco smoke are potentially modifiable risk factors for greater ED use in children with SCD. Low income is associated with greater ED use for SCD pain in countries with and without universal health care.
© 2012 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687181      PMCID: PMC3375948          DOI: 10.1111/j.1553-2712.2012.01364.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  37 in total

1.  Methods for using data abstracted from medical charts to impute longitudinal missing data in a clinical trial.

Authors:  Paul L Hebert; Leslie T Taylor; Jason J Wang; Margo A Bergman
Journal:  Value Health       Date:  2011-10-12       Impact factor: 5.725

2.  Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease.

Authors:  Robyn T Cohen; Michael R DeBaun; Morey A Blinder; Robert C Strunk; Joshua J Field
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

Review 3.  Access to health and health care: how race and ethnicity matter.

Authors:  Lynne D Richardson; Marlaina Norris
Journal:  Mt Sinai J Med       Date:  2010 Mar-Apr

4.  Population estimates of sickle cell disease in the U.S.

Authors:  Kathryn L Hassell
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

Review 5.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

6.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

7.  Estimated deaths attributable to social factors in the United States.

Authors:  Sandro Galea; Melissa Tracy; Katherine J Hoggatt; Charles Dimaggio; Adam Karpati
Journal:  Am J Public Health       Date:  2011-06-16       Impact factor: 9.308

8.  Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice.

Authors:  Kirkwood A Pritchard; Thom R Feroah; Sandhya D Nandedkar; Sandra L Holzhauer; William Hutchins; Marie L Schulte; Robert C Strunk; Michael R Debaun; Cheryl A Hillery
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

9.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 10.  Asthma in sickle cell disease.

Authors:  Manisha Newaskar; Karen A Hardy; Claudia R Morris
Journal:  ScientificWorldJournal       Date:  2011-05-26
View more
  13 in total

Review 1.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

2.  Simulation of various randomization strategies for a clinical trial in sickle cell disease.

Authors:  William J Meurer; Jason T Connor; Jeffrey Glassberg
Journal:  Hematology       Date:  2016-03-16       Impact factor: 2.269

3.  Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.

Authors:  Jeffrey Glassberg; Caterina Minnitti; Caroline Cromwell; Lawrence Cytryn; Thomas Kraus; Gwen S Skloot; Jason T Connor; Adeeb H Rahman; William J Meurer
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

4.  Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments.

Authors:  David Schnadower; Phillip I Tarr; Marc H Gorelick; Karen O'Connell; Cindy G Roskind; Elizabeth C Powell; Jayashree Rao; Seema Bhatt; Stephen B Freedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-10       Impact factor: 2.839

5.  Preliminary exploration of secondhand smoke exposure in youth with Sickle Cell Disease: biochemical verification, pulmonary functioning, and health care utilization.

Authors:  Alayna P Tackett; Eleanor L S Leavens; Alex Wiedenmann; Megan N Perez; Ashley Baker; Sunnye Mayes; Larry L Mullins; Theodore L Wagener
Journal:  Psychol Health Med       Date:  2018-09-11       Impact factor: 2.423

6.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Catherine Kimber; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06

Review 7.  Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research.

Authors:  S Christy Sadreameli; Benjamin T Kopp; Susan E Creary; Michelle N Eakin; Sharon McGrath-Morrow; John J Strouse
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

8.  Nocturnal hypoxemia measured by polysomnogram is associated with acute chest syndrome in pediatric sickle cell disease.

Authors:  Anis Rabbani Nourani; A K M Fazlur Rahman; Brandi Pernell; Mary H Maddox; Lee Hilliard; Jeffrey Lebensburger; Ammar Saadoon Alishlash
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

9.  Blood transfusions for treating acute chest syndrome in people with sickle cell disease.

Authors:  Roya Dolatkhah; Saeed Dastgiri
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

Review 10.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.